CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Evaluate the expected performance of Pfizer (PFE) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics ...

CRISPR Therapeutics (CRSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nvidia is the world's leading supplier of artificial intelligence (AI) chips for data centers. The company is scheduled to release its operating results for its fiscal 2026 third quarter on Nov. 19, ...

CRISPR Therapeutics (NASDAQ:CRSP) has filed a prospectus supplement with the U.S. SEC to sell up to $600 million worth of its common shares through Jefferies LLC, acting as its sales agent. The sale ...

Crispr Therapeutics maintains leadership in gene editing, with shares up 75% YTD and renewed investor interest after positive CTX-310 data. CRSP's in-vivo therapy shows promising early results, ...

In the latest close session, CRISPR Therapeutics AG (CRSP) was down 6.54% at $68.29. The stock trailed the S&P 500, which registered a daily gain of 1.56%. On the other hand, the Dow registered a gain ...

Money-line favorites in the NFL had a rough Week 5, going 7-7 straight-up. Given the uncertainty, hitting on exact NFL score predictions could result in a huge payday of around 100-1. Can the Ravens ...

The record-setting run in gold continues. Gold futures, which settled above $4,000 for the first time on Tuesday, rose more than 1% Wednesday to a new high. Silver prices also rose, bringing them ...

Gambling content 21+. The New York Post may receive an affiliate commission if you sign up through our links. Read our editorial standards for more information. The Canadiens and Maple Leafs will ...

View post: Blue Jays Announce Troubling Anthony Santander Development Before Mariners Game Missouri State is a slight favorite over Middle Tennessee despite QB Jacob Clark's injury uncertainty. Both ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. It can be pretty tough to predict when the next share ...